|
1
|
Huang SH and O’Sullivan B: Oral cancer:
Current role of radiotherapy and chemotherapy. Med Oral Patol Oral
Cir Bucal. 18:e233–e240. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sharma M, Sah P, Sharma SS and
Radhakrishnan R: Molecular changes in invasive front of oral
cancer. J Oral Maxillofac Pathol. 17:240–247. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Silva TD, Vidigal VM, Felipe AV, DE Lima
JM, Neto RA, Saad SS and Forones NM: DNA methylation as an
epigenetic biomarker in colorectal cancer. Oncol Lett. 6:1687–1692.
2013.PubMed/NCBI
|
|
4
|
Tam WL and Weinberg RA: The epigenetics of
epithelial-mesenchymal plasticity in cancer. Nat Med. 19:1438–1449.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Marcinkiewicz KM and Gudas LJ: Altered
epigenetic regulation of homeobox genes in human oral squamous cell
carcinoma cells. Exp Cell Res. 320:128–143. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
González-Ramírez I, García-Cuellar C,
Sánchez-Pérez Y and Granados-García M: DNA methylation in oral
squamous cell carcinoma: molecular mechanisms and clinical
implications. Oral Dis. 17:771–778. 2011.PubMed/NCBI
|
|
7
|
Tsao CM, Yan MD, Shih YL, Yu PN, Kuo CC,
Lin WC, et al: SOX1 functions as a tumor suppressor by antagonizing
the WNT/β-catenin signaling pathway in hepatocellular carcinoma.
Hepatology. 56:2277–2287. 2012.PubMed/NCBI
|
|
8
|
Schütz AK, Hennes T, Jumpertz S, Fuchs S
and Bernhagen J: Role of CSN5/JAB1 in Wnt/β-catenin activation in
colorectal cancer cells. FEBS Lett. 586:1645–1651. 2012.
|
|
9
|
O’Hurley G, Perry AS, O’Grady A, Loftus B,
Smyth P, O’Leary JJ, et al: The role of secreted frizzled-related
protein 2 expression in prostate cancer. Histopathology.
59:1240–1248. 2011.PubMed/NCBI
|
|
10
|
Kinoshita T, Nomoto S, Kodera Y, Koike M,
Fujiwara M and Nakao A: Decreased expression and aberrant
hypermethylation of the SFRP genes in human gastric cancer.
Hepatogastroenterology. 58:1051–1056. 2011.PubMed/NCBI
|
|
11
|
von Marschall Z and Fisher LW: Secreted
Frizzled-related protein-2 (sFRP2) augments canonical Wnt3a-induced
signaling. Biochem Biophys Res Commun. 400:299–304. 2010.PubMed/NCBI
|
|
12
|
Li YY, Qin YZ, Wang RQ, Li WB and Qu XJ:
SL-01, an oral derivative of gemcitabine, inhibited human breast
cancer growth through induction of apoptosis. Biochem Biophys Res
Commun. 438:402–409. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun Y, Ho GH, Koong HN, Sivaramakrishnan
G, Ang WT, Koh QM and Lin VC: Down-regulation of tripartite-motif
containing 22 expression in breast cancer is associated with a lack
of p53-mediated induction. Biochem Biophys Res Commun. 44:600–606.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
de Freitas Cordeiro-Silva M, Stur E,
Agostini LP, de Podestá JR, de Oliveira JC, Soares MS, et al:
Promoter hypermethylation in primary squamous cell carcinoma of the
oral cavity and oropharynx: a study of a Brazilian cohort. Mol Biol
Rep. 39:10111–10119. 2012.PubMed/NCBI
|
|
15
|
Ovchinnikov DA, Cooper MA, Pandit P, Coman
WB, Cooper-White JJ, Keith P, et al: Tumor-suppressor gene promoter
hypermethylation in saliva of head and neck cancer patients. Transl
Oncol. 5:321–326. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jost E, Gezer D, Wilop S, Suzuki H, Herman
JG, Osieka R and Galm O: Epigenetic dysregulation of secreted
Frizzled-related proteins in multiple myeloma. Cancer Lett.
281:24–31. 2009. View Article : Google Scholar
|
|
17
|
Cheng YY, Yu J, Wong YP, Man EP, To KF,
Jin VX, et al: Frequent epigenetic inactivation of secreted
frizzled-related protein 2 (SFRP2) by promoter methylation in human
gastric cancer. Br J Cancer. 97:895–901. 2007.PubMed/NCBI
|
|
18
|
Lachenmayer A, Alsinet C, Savic R,
Cabellos L, Toffanin S, Hoshida Y, et al: Wnt-pathway activation in
two molecular classes of hepatocellular carcinoma and experimental
modulation by sorafenib. Clin Cancer Res. 18:4997–5007. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jia Y, Yang Y, Brock MV, Zhan Q, Herman JG
and Guo M: Epigenetic regulation of DACT2, a key component of the
Wnt signalling pathway in human lung cancer. J Pathol. 230:194–204.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lavergne E, Hendaoui I, Coulouarn C,
Ribault C, Leseur J, Eliat PA, et al: Blocking Wnt signaling by
SFRP-like molecules inhibits in vivo cell proliferation and tumor
growth in cells carrying active β-catenin. Oncogene. 30:423–433.
2011.PubMed/NCBI
|
|
21
|
Guo Y, Guo W, Chen Z, Kuang G, Yang Z and
Dong Z: Hypermethylation and aberrant expression of Wnt-antagonist
family genes in gastric cardia adenocarcinoma. Neoplasma.
58:110–117. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kongkham PN, Northcott PA, Croul SE, Smith
CA, Taylor MD and Rutka JT: The SFRP family of WNT inhibitors
function as novel tumor suppressor genes epigenetically silenced in
medulloblastoma. Oncogene. 29:3017–3024. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang Y and Chen H: Genistein attenuates
WNT signaling by up-regulating sFRP2 in a human colon cancer cell
line. Exp Biol Med (Maywood). 236:714–722. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chung MT, Lai HC, Sytwu HK, Yan MD, Shih
YL, Chang CC, et al: SFRP1 and SFRP2 suppress the transformation
and invasion abilities of cervical cancer cells through Wnt signal
pathway. Gynecol Oncol. 112:646–653. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fu Y, Zheng S, An N, Athanasopoulos T,
Popplewell L, Liang A, et al: β-catenin as a potential key target
for tumor suppression. Int J Cancer. 129:1541–1551. 2011.
|
|
26
|
Webster MR and Weeraratna AT: A Wnt-er
migration: the confusing role of β-catenin in melanoma metastasis.
Sci Signal. 6:pe112013.PubMed/NCBI
|
|
27
|
Kim W, Kim M and Jho EH: Wnt/β-catenin
signalling: from plasma membrane to nucleus. Biochem J. 450:9–21.
2013.
|
|
28
|
Valenta T, Hausmann G and Basler K: The
many faces and functions of β-catenin. EMBO J. 31:2714–2736.
2012.
|
|
29
|
Umbreit C, Aderhold C, Faber A, Sommer JU,
Sauter A, Hofheinz RD, et al: Unexpected alteration of β-catenin
and c-KIT expression by 5-FU and docetaxel in p16-positive squamous
cell carcinoma compared to HPV-negative HNSCC cells in vitro.
Anticancer Res. 33:2457–2465. 2013.
|
|
30
|
Ebrahimi M, Boldrup L, Wahlin YB, Coates
PJ and Nylander K: Decreased expression of the p63 related proteins
beta-catenin, E-cadherin and EGFR in oral lichen planus. Oral
Oncol. 44:634–638. 2008. View Article : Google Scholar
|
|
31
|
Li GH, Cui YS, Wu QY, Zhang XJ and Gao YF:
Clinicopathologic significance of β-catenin and matrix
metalloproteinase-2 expression in non-small cell lung cancer. Med
Oncol. 30:4372013.
|
|
32
|
Monga SP: Role of Wnt/β-catenin signaling
in liver metabolism and cancer. Int J Biochem Cell Biol.
43:1021–1029. 2011.
|
